MedSmart Group Inc.
MedSmart Group Inc. (MSGP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
msgp · pe ratio · data through Dec 31, 2021
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for MedSmart Group Inc. (MSGP) measures how much investors pay for each dollar of the company's trailing earnings. MSGP's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2021-12-31
PE Ratio History
2003 – 2021 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%0.5x
MedianQ3 · 75%14.1x
Max
At N/A, MSGP's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MedSmart Group Inc.You MSGP | $0M | N/A | — | -$0.00 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 Calithera Biosciences, Inc. CALA | $0M | N/A | — | -$3.78 |
 InnerScope Hearing Technologies, Inc. INND | $0M | N/A | — | -$0.00 |
 Inyx, Inc. IYXI | $0M | N/A | — | -$0.78 |
 Panacos Pharmaceuticals, Inc. PANC | $0M | N/A | — | -$0.70 |
 SpectraScience, Inc. SCIE | $0M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2021-12-31Latest FY2021 | — | $-0.00 | — | |
2020-12-31 FY2020 | — | $-0.06 | — | |
2019-12-31 FY2019 | — | $-0.10 | — | |
2018-12-31 FY2018 | 0.55x | $0.92 | -83.5% | |
2017-12-31 FY2017 | 3.31x | $0.30 | -76.6% | |
2016-12-31 FY2016 | 14.12x | $0.04 | +13367.8% | |
2013-12-31 FY2013 | 0.10x | $4.77 | — | |
2012-12-31 FY2012 | — | $-196.94 | — | |
2011-12-31 FY2011 | — | $-369.56 | — | |
2010-12-31 FY2010 | — | $-3178.40 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MedSmart Group Inc. (MSGP) measures how much investors pay for each dollar of the company's trailing earnings. MSGP's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Frequently asked questions
MSGP pe ratio · 6 questionsMSGP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via MSGP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MedSmart Group Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09